Consensus Position Statement on Emerging Treatments in Dermatology by the Association of Cutaneous Surgeons of India Task Force

    February 2026 in “ Journal of Cutaneous and Aesthetic Surgery ”
    Venkataram Mysore, Gulhima Arora, B. S. Chandrashekar, Niti Khunger, Rasya Dixit, Shehnaz Zulfikar Arsiwala, Shuken Dashore, Swapnil Shah, Thaís Rocha Salim, Biju Vasudevan, Pradeep Kumari, Amit Shivaji Kerure, C. Madura, Ambika Dixit
    New to Exosomes? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this consensus statement, the Task Force of the Association of Cutaneous Surgeons of India found that over 90% of their experts agreed on the evidence strength, recommendation levels, and safety of six emerging dermatology treatments, providing guidelines for their clinical use.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The consensus position statement by the Association of Cutaneous Surgeons of India Task Force evaluates six emerging dermatological treatments, including exosomes, PDRNs, and Regenera Activa, focusing on their potential in hair growth and other skin conditions. The study, involving 14 dermatologists, found that most treatments lack robust evidence and FDA approval, with recommendations ranging from moderate to limited. Exosomes and PDRNs show potential but are largely preclinical, while Regenera Activa shows promise in hair loss but requires further research. For androgenetic alopecia, small studies show improvements, but evidence is low, necessitating more robust trials. The document emphasizes cautious use of these treatments under ethical oversight, highlighting the need for informed consent and further research to ensure safety and efficacy.
    Discuss this study in the Community →

    Research cited in this study

    39 / 39 results